Analysts' Top Healthcare Picks: Stereotaxis (STXS), Capricor Therapeutics (CAPR)
Analysts Are Bullish on Top Healthcare Stocks: Joint (JYNT), Stereotaxis (STXS)
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
Stereotaxis Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Stereotaxis (STXS), LifeMD (LFMD)
Stereotaxis (STXS) Gets a Buy From Lake Street
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Roth MKM Initiates Coverage On Stereotaxis With Buy Rating, Announces Price Target of $5
Stereotaxis Analyst Ratings
Stereotaxis's Growth Trajectory: A Buy Rating With a Focus on Innovation and Expanding Markets
Stereotaxis (STXS) Gets a Buy From Craig-Hallum
Craig-Hallum Keeps Their Buy Rating on Stereotaxis (STXS)
Analysts' Top Healthcare Picks: Aura Biosciences Inc (AURA), Stereotaxis (STXS)
Stereotaxis: Promising Developments and Financial Stability Maintain Buy Rating Despite Minor Setbacks
Analysts Are Bullish on Top Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Stereotaxis (STXS)
Craig-Hallum Keeps Their Buy Rating on Stereotaxis (STXS)
Analysts Are Bullish on Top Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Stereotaxis (STXS)
B. Riley Adjusts Price Target on Stereotaxis to $4.50 From $5.50, Maintains Buy Rating
B.Riley Financial Remains a Buy on Stereotaxis (STXS)
No Data